FAQs

What makes CMS different?

CMS provides:

  • Clear understanding of your business and what is required to assist you in managing your service needs
  • Proper, clear and accurate ways to schedule and document services
  • WebPortal with processed documents available via secure access
  • WebPortal status of services and/or an emailed status summary of services daily
  • Negative drug screens reported in less than 7 minutes from the release at the lab
  • Live customer service representative available by phone during business hours
  • 24/7 In-house assistance for Post-Accident drug or drug & alcohol screening
  • Skilled medical staff to review DOT Physicals for accuracy and completeness
  • Sleep Apnea Program that costs less than $1,000 and is completed in less than a week
  • Invoice reconciliation and consolidation resulting in one invoice each month
How hard is it to transfer my business to CMS?

It couldn’t be easier. With a handshake, CMS will set the following in motion to get service started in as little as one day.

Your part:

  • Provide a list of your staff with authorization to schedule services and/or receive results
  • Provide a list of clinics or areas you prefer

CMS’s part:

  • Provide a fee schedule or service agreement
  • Establish Collection Sites
  • Establish Lab Account
  • Notify company as each clinic is ready to provide services for employees or prospects
  • Add clinics to the CMS WebPortal for future scheduling
How many drug screens does CMS report per year?

This year we expect to report over 100,000 drug screens with the majority of negatives being reported to our clients in less than seven minutes after being released from the lab.

How does the drug screen process work?

Drug Screening is complex by design. Similar to our form of government, there are three different and distinct components which produce the final report. At each stage, there are very specific requirement in place to ensure the highest integrity in the testing process:

The Collector
Requires Certification Training (49 CFR Part 40.31)

The Lab
The lab must be approved and in good standing by the Substance Abuse and Mental Health Services Administration (SAMHSA)

The Medical Review Officer (MRO)
The MRO is the final step in the process. The MRO reviews the services of both the Collector and the Lab to ensure accuracy, and then reviews the details of the Lab’s report.

What are DOT Random Testing Rates?
DOT Agency 2018 Random (Drug Screen) 2018 Random Rate (Alcohol Screen) Regulation
Trucking Industry (FMCSA) 25% 10% 49 CFR Part 382
School and City Bus Industry (FTA) 25% 10% 49 CFR Part 655
Pipeline & Hazardous Materials (PHMSA) 50% N/A
How do alternative specimen testing methods compare to urine drug testing?
Method Need a Bathroom Privacy Issue Collector Certification DOT Approved Test Window
Urine Yes Yes Yes Yes 1-30 Hours
Oral Fluids No No Yes No 1–30 Hours
Hair No No Yes No 5-90 Days
What is a Medical Review Officer (MRO), and why do I need one?

The Medical Review Officer (MRO) is best defined by reading 49 CFR Part 40.121. The basic requirements are:

  • Must be a licensed physician (Doctor of Medicine or Osteopathy)
  • Must be knowledgeable about, and have clinical experience in, controlled substance abuse disorders. This includes detailed knowledge of alternative medical explanations for laboratory-confirmed drug test results.
  • Must understand all components of the drug screening process including the collection and laboratory processes.
Why should I drug test my employees?
  • Historically, even ‘recreational users’ have greater absentee rates and more ‘on the job’ injuries than non-users.
  • Productivity rates. If an employee is not present you must reschedule others to ‘work around’ those who are absent, causing lower production.
  • Quality employees are attracted to a safe working environment.
  • There are often significant insurance savings with a Drug-Free Work Place Program.
  • Advertising that your business is “Drug-Free” is a great marketing and sales tool.
What are the risks and costs of not drug testing?

Companies that have a decent drug-free workplace program receive discounts up to 15% on worker’s compensation premiums. They know that employees who use drugs are more prone to accidents and that their costs (medical, lost wages and settlement) would be greater without a program in place.

Am I notified of safety risk?

The MRO (Medical Review Officer) who evaluates a test result has the duty to report safety risks due to medication as described in 49CFR§40.327. While this duty has existed since the year 2000, the addition of opioids to the test panel beginning January 1, 2018 has the potential to significantly increase the number of safety risk notices provided to employers. New DOT regulations 49CFR§40.135(e) have also introduced a 5 day “pause” before the MRO is allowed to issue this notice AFTER the Negative Result is reported to the company.

What conditions create a potential safety risk?

The Final Rule “leave(s) the determination of the significant safety risk to the “reasonable medical judgment” of the MRO”. For clarification and to set expectations with our clients, CMS policy is as follows:

  1. Any donor who is identified during the confidential interview or prescription validation process as having continued access to opioids has the ability to legally ingest that medication while performing Safety-Sensitive functions. Performing Safety-Sensitive functions while under the influence of opioids may constitute a safety risk. All safety risks will be verbally reported to the DER (Designated Employer Representative) to be evaluated by company policy or a Certified Medical Examiner
  2. The donor will be notified of the pending safety risk notice and informed that their prescribing physician has five (5) business days to contact CMS to discuss changing their medication before the safety risk is sent to the employer. The donor will be informed, but not directed, that they may contact their safety department to determine how to resolve any safety risks before the official notice is given. As long as the donor has legal access to the medication, the safety risk will be reported as soon as possible under regulations.
  3. A five (5) business day waiting period will be observed from the date of reporting a verified negative result to reporting the associated safety notice as per the regulations.
What should you do with a safety risk notice?

Evaluating your company policy should be the first step when receiving a safety risk notice. Some company policies have a zero-tolerance of narcotic, opioid, or other medications, some company policies allow such medications only when off-duty, and other company policies allow any medication when prescribed by a doctor. If in doubt, the employee should be evaluated by a Certified Medical Examiner with a DOT Physical Examination.

Questions?

CMS is always available to answer questions for our clients. Please call the phone number above or email us at MRO@CorporateMedicalServices.com, and we will help resolve any questions.